Uvre Limited (UVA.AX)
AUD 0.09
(-10.53%)
AUD 0.09
(-10.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -1.31 Million | -1.58 Million | -165.51 Thousand | -210.00 |
| Net Income | -1.24 Million | -2.08 Million | -1.21 Million | -8136.00 |
| Depreciation & Amortization | - | - | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 31.5 Thousand | 307.73 Thousand | 1.08 Million | - |
| Change in working capital | -64.2 Thousand | 41.99 Thousand | -71.07 Thousand | -210.00 |
| Other non-cash items | -40.11 Thousand | 149.39 Thousand | 33.02 Thousand | 8346.00 |
| Investing Cash Flow | -162.14 Thousand | -1.00 | -233.15 Thousand | - |
| Investments in PPE | -162.14 Thousand | - | -233.15 Thousand | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -162.14 Thousand | - | - | - |
| Financing Cash Flow | 1.17 Million | -5000.00 | 5.74 Million | 6.00 |
| Debt repayment | - | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | -75 Thousand | -5000.00 | -555.88 Thousand | - |
| Common Stock Issuance | 1.25 Million | - | 6.3 Million | - |
| Other Financing Activities | 1.17 Million | -5000.00 | 5.74 Million | 6.00 |
| Accounts receivables | -64.2 Thousand | 41.99 Thousand | -71.07 Thousand | -210.00 |
| Accounts payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | - | - | - | - |
| Cash at beginning of period | 3.73 Million | 5.34 Million | 1.00 | 5.99 |
| Cash at end of period | 3.37 Million | 3.73 Million | 5.34 Million | -204.00 |
| Capital Expenditure | -162.14 Thousand | - | -233.15 Thousand | - |
| Effect of forex changes on cash | -50.26 Thousand | -28.36 Thousand | - | - |
| Net cash flow / Change in cash | -355.77 Thousand | -1.61 Million | 5.34 Million | -209.99 |
| Free Cash Flow | -1.48 Million | -1.58 Million | -398.67 Thousand | -210.00 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -253.04 | -253.04 | -369.74 | -369.74 | -2.08 Million | -540.75 |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 7.83 | 7.83 | 7.92 | 7.92 | 307.73 Thousand | 131.83 |
| Change in working capital | -32.10 | -32.10 | - | - | 41.99 Thousand | 21.00 |
| Other non-cash items | -60.62 | -60.62 | 40.56 | 40.56 | 149.39 Thousand | 24.01 |
| Investing Cash Flow | -25.40 | -25.40 | -55.67 | -55.67 | -1.00 | - |
| Investments in PPE | -25.40 | -25.40 | -55.67 | -55.67 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 587.50 | 587.50 | - | - | -5000.00 | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -5000.00 | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 587.50 | 587.50 | - | - | -5000.00 | - |
| Accounts receivables | -32.10 | -32.10 | - | - | 41.99 Thousand | 21.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | - | 5.34 Million | -377.71 Thousand |
| Cash at end of period | 239.85 | 239.85 | -417.73 | -417.73 | 3.73 Million | -378.09 Thousand |
| Capital Expenditure | -25.40 | -25.40 | -55.67 | -55.67 | - | - |
| Effect of forex changes on cash | 15.67 | 15.67 | -40.80 | -40.80 | -28.36 Thousand | -14.19 |
| Net cash flow / Change in cash | 239.85 | 239.85 | -417.73 | -417.73 | -1.61 Million | -378.09 |
| Free Cash Flow | -363.32 | -363.32 | -376.93 | -376.93 | -1.58 Million | -363.90 |
002487
HEM
PHLI
688418
LBTD
ENJ